- Home
- HAO vs INM Comparison
HAO vs INM Comparison
Compare HAO & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HAO
- INM
- Stock Information
- Founded
- HAO 2018
- INM 1981
- Country
- HAO China
- INM Canada
- Employees
- HAO N/A
- INM N/A
- Industry
- HAO
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- HAO
- INM Health Care
- Exchange
- HAO NYSE
- INM Nasdaq
- Market Cap
- HAO 3.3M
- INM 3.2M
- IPO Year
- HAO 2024
- INM N/A
- Fundamental
- Price
- HAO $1.27
- INM $3.33
- Analyst Decision
- HAO
- INM
- Analyst Count
- HAO 0
- INM 0
- Target Price
- HAO N/A
- INM N/A
- AVG Volume (30 Days)
- HAO 67.5K
- INM 9.5M
- Earning Date
- HAO 07-07-2025
- INM 05-12-2025
- Dividend Yield
- HAO N/A
- INM N/A
- EPS Growth
- HAO N/A
- INM N/A
- EPS
- HAO 0.19
- INM N/A
- Revenue
- HAO $48,970,924.00
- INM $4,920,990.00
- Revenue This Year
- HAO N/A
- INM N/A
- Revenue Next Year
- HAO N/A
- INM N/A
- P/E Ratio
- HAO $6.60
- INM N/A
- Revenue Growth
- HAO 15.04
- INM N/A
- 52 Week Low
- HAO $0.84
- INM $1.72
- 52 Week High
- HAO $173.25
- INM $15.70
- Technical
- Relative Strength Index (RSI)
- HAO 46.49
- INM 59.24
- Support Level
- HAO $1.18
- INM $2.26
- Resistance Level
- HAO $1.31
- INM $5.50
- Average True Range (ATR)
- HAO 0.08
- INM 0.40
- MACD
- HAO -0.00
- INM 0.11
- Stochastic Oscillator
- HAO 46.63
- INM 37.04
About HAO HAOXI HEALTH TECHNOLOGY LTD
Haoxi Health Technology Ltd is an online marketing solution provider in China, with an advertiser client base mainly in the healthcare industry. Haoxi has been rooted in the field of local online effect marketing for many years, serving customers in various industries at home and abroad, and its main business is the medical industry. It generates its revenue by providing one-stop online marketing solutions, in particular online short video marketing solutions, to advertisers through its media partners. The company provides customized marketing solutions by planning, producing, placing, and optimizing online ads, especially online short video ads, to help its advertisers acquire, convert, and retain ultimate consumers on various online media platforms.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.